UBIO
Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO
Delisted
UBIO was delisted on the 27th of March, 2020.
4 hedge funds and large institutions have $293K invested in Proshares UltraPro NASDAQ Biotechnology in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
2
Calls
–
Puts
$4K
Net Calls
-$4K
Net Calls Change
-$293K
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Jane Street
New York
|
-$553K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$391K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$34.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$34.3K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $263K | -$34.4K | -1,821 | -12% |
|
2
Morgan Stanley
New York
| $15K | – | – | – |
|
|
LTFS
3
Ladenburg Thalmann Financial Services
Miami,
Florida
| $14K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $1K | -$34.3K | -2,128 | -97% |
|
|
5
Jane Street
New York
| – | -$553K | -21,385 | Closed |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$391K | -15,074 | Closed |
|